Full-Time

Manager EH&S

Posted on 10/31/2025

Sotera Health

Sotera Health

1,001-5,000 employees

Outsourced sterilization and lab testing provider.

No salary listed

El Paso, TX, USA

In Person

Approximate overnight travel required: 30%.

Category
Security & Protective Services
Requirements
  • Bachelor’s Degree, in a technical discipline
  • Seven or more years of Environmental, Health & Safety experience, preferably in the medical device or pharmaceutical or chemical industries.
  • Strong knowledge of Federal, state, and local EH&S related regulations.
  • Basic understanding of OSHA Process Safety Management and/or EPA Risk Management Program.
  • Computer proficiency ability, Microsoft Office preferred.
  • Excellent written and verbal communication skills.
  • Well organized, ability to manage multiple locations and projects
  • Approximate overnight travel required: 30%
Responsibilities
  • Environmental Support: Become familiar with federal, state and local environmental (air, waste, water) requirements for identified plants.
  • Environmental Support: Provide ongoing support and training to the plants for compliance with the current environmental requirements.
  • Environmental Support: Develop working relationships with appropriate state and local environmental regulatory parties.
  • Environmental Support: Prepare environmental permit applications, when needed. Also prepare and submit regulatory agency reports.
  • Environmental Support: Coordinate and support compliance testing.
  • Environmental Support: Work closely with Operations, Engineering, and QA departments to ensure continued EH&S compliance and further support EH&S corporate initiatives.
  • Health & Safety Support: Support ongoing implementation of the Corporate EH&S System at identified plants including the development of standards and work instructions.
  • Health & Safety Support: Provide training and training materials to the plants for required safety training topics.
  • Health & Safety Support: Monitor the industrial hygiene testing results and follow-up, including assistance with action plans, as needed for identified plants.
  • Health & Safety Support: Assist plant safety committees as needed to improve the safety awareness in identified plants.
  • Health & Safety Support: Support implementation of Process Safety Management and Risk Management Programs at designated US facilities.
  • Health & Safety Support: Conduct Process Hazard Analysis and/or Risk Assessments and follow up on any issues generated.
  • Health & Safety Support: Assist in Worker Compensation claim management.
  • Health & Safety Support: Conduct incident investigations and corrective/preventative actions for all incidents. Assist the facility in incident tracking and trend evaluations.
  • Health & Safety Support: Participate in and conduct periodic inspections and lead EH&S Corporate Audits for all facilities. Follow up on all items with appropriate management.

Sotera Health provides sterilization and lab testing services to ensure the safety of medical devices, pharmaceuticals, and food products. The company operates through three divisions: Sterigenics, which uses methods like Gamma and X-ray to eliminate contaminants; Nordion, which supplies the Cobalt-60 isotopes needed for irradiation; and Nelson Labs, which performs over 800 microbiological and analytical tests. Unlike many competitors, it offers a fully integrated supply chain by producing its own sterilization sources while maintaining a global network of 63 facilities and labs. Its goal is to protect global health by providing the mission-critical services required to bring safe healthcare products to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Broadview Heights, Ohio

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $280M, beating estimates with 10% growth and 48.1% EBITDA margin.
  • Sessa Capital bought $175.8M stake in Q4 2025, signaling investor confidence.
  • CFO guides 5-6.5% organic growth for 2026, targeting $500-600M free cash flow.

What critics are saying

  • EPA restricts EtO facilities at Sterigenics, slashing 8% volume growth in 6-12 months.
  • Nordion's Cobalt-60 supply fails from aging reactors, crippling gamma operations in 12-24 months.
  • Q1 2026 free cash flow drops to negative $16.73M, breaching debt covenants in 6-12 months.

What makes Sotera Health unique

  • Sotera Health integrates Sterigenics, Nordion, and Nelson Labs for end-to-end sterilization and testing.
  • Nordion supplies Cobalt-60 isotopes essential for Sterigenics' gamma sterilization worldwide.
  • Nelson Labs performs over 900 microbiological tests across 15 global labs for validation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Education Assistance

Employee Assistance Program (EAP)

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Globe and Mail
Mar 24th, 2026
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

Detailed price information for Capital One Financial Corp (COF-N) from The Globe and Mail including charting and trades.

Intellectia.AI
Mar 23rd, 2026
Sessa Capital buys $175.8M stake in Sotera Health as shares outperform S&P 500

Sessa Capital has acquired an additional 10,630,381 shares of Sotera Health for approximately $175.80 million on 17 February 2026, bringing its quarter-end position value to $206.47 million. The transaction signals strong confidence in the healthcare services company. Sotera Health shares traded at $13.99 on Monday, representing an 18% gain over the past year, slightly outperforming the S&P 500's 15% increase. The company has generated revenue of approximately $1.16 billion and adjusted EBITDA near $600 million. Despite facing litigation and regulatory risks, Sotera Health's sustained growth potential continues attracting long-term investor interest. The substantial investment by Sessa Capital reinforces the company's position within the asset manager's portfolio.

Yahoo Finance
Mar 23rd, 2026
Sessa Capital invests $175M in Sotera Health following 21% stock drop

Sessa Capital purchased 10.63 million shares of Sotera Health in the fourth quarter for an estimated $175.80 million, according to a Securities and Exchange Commission filing dated 17 February. The stake now represents nearly 7% of Sessa Capital's reportable assets under management. Sotera Health provides sterilisation services and laboratory testing for medical device and pharmaceutical industries. The company generated $1.2 billion in revenue and $77.9 million in net income over the trailing twelve months. Despite 20 years of steady growth and adjusted EBITDA approaching $600 million, the stock has declined as investors focus on litigation risks, high leverage and regulatory concerns. The shares currently trade at $13.99, up 18% over the past year, with a market capitalisation of $4.0 billion.

Yahoo Finance
Mar 22nd, 2026
Sotera Health CFO reaffirms 5%–6.5% organic growth for 2026, eyes $500M–$600M free cash flow

Sotera Health's CFO Jon Lyons reaffirmed constant-currency organic growth guidance of 5% to 6.5% for 2026 at the KeyBanc Healthcare Forum. Sterigenics is expected to deliver mid- to high-single-digit growth, whilst Nordion and Nelson Labs will see lower-single-digit growth. The company closed 2025 with 5.2% organic revenue growth, maintaining over 50% EBITDA margins with a 118-basis-point improvement. Weaker Nelson Labs results were offset by stronger Sterigenics volumes of approximately 8%. Management prioritises free cash flow and capital discipline, targeting $500 million to $600 million over three years. Capital expenditure is expected to drop significantly in 2027 as projects complete. Net leverage has improved towards the 2x–3x target, providing flexibility for debt reduction, acquisitions or share buybacks.

Yahoo Finance
Mar 2nd, 2026
Sotera Health up 30% in a year as fund trims $3.6M stake but maintains conviction

Ananym Capital Management sold 217,684 shares of Sotera Health for an estimated $3.60 million in February 2026, according to an SEC filing. Despite the sale, Sotera Health remains a significant holding at 8.65% of Ananym's assets under management. Sotera Health shares were trading at $17.09 as of 17 February 2026, up nearly 30% over the past year and outperforming the S&P 500 by 14.86 percentage points. The company provides sterilisation services and laboratory testing for medical device, pharmaceutical and food industries. Sotera recently reported its 20th consecutive year of revenue growth, with 2025 revenues rising nearly 6% to $1.16 billion. Management has guided for another 5% to 6.5% revenue increase in 2026, with adjusted EBITDA growth of 5.5% to 7%.

INACTIVE